Yonhap Infomax NewsJan 8
Hana Ventures has appointed Kim Sung Eun, first author of a Nobel Prize-winning paper and founder of Panoros Biosciences, to strengthen its bio investment capabilities and expand its biotech portfolio amid renewed sector optimism.
#YonhapInfomax #HanaVentures #KimSungEun #BioInvestment #NobelPrize #PanorosBiosciences #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=98897
Hana Ventures Strengthens Bio Investment Capabilities with Appointment of Nobel Prize Paper First Author

Hana Ventures has appointed Kim Sung Eun, first author of a Nobel Prize-winning paper and founder of Panoros Biosciences, to strengthen its bio investment capabilities and expand its biotech portfolio amid renewed sector optimism.

Yonhap Infomax
Yonhap Infomax NewsNov 3
Samsung Epys Holdings, spun off from Samsung Biologics, officially launched as a bio investment holding company, aiming to drive growth through new biotech subsidiaries and aggressive R&D, while Samsung Biologics shifts to a pure-play CDMO model with expanded production capacity and global client base.
#YonhapInfomax #SamsungEpysHoldings #SamsungBiologics #BioInvestment #CDMO #ProductionCapacity #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88882
Samsung Epys Holdings Officially Launches as Bio Investment Holding Company—Eyes New Business Opportunities

Samsung Epys Holdings, spun off from Samsung Biologics, officially launched as a bio investment holding company, aiming to drive growth through new biotech subsidiaries and aggressive R&D, while Samsung Biologics shifts to a pure-play CDMO model with expanded production capacity and global client base.

Yonhap Infomax